Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Spire Healthcare ( (GB:SPI) ) is now available.
Spire Healthcare has confirmed that private equity firms Bridgepoint Advisers and Triton Investment Advisers are among the parties in preliminary talks with the company as part of the strategic review launched in September 2025, following recent media speculation. The discussions may or may not lead to a formal takeover offer, with both suitors facing a regulatory deadline of 21 February 2026 to either announce a firm intention to bid or walk away under UK takeover rules, underscoring the possibility of significant corporate change for the FTSE 250 healthcare group but with no certainty yet for shareholders, staff or other stakeholders.
The most recent analyst rating on (GB:SPI) stock is a Hold with a £187.00 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on GB:SPI Stock
According to Spark, TipRanks’ AI Analyst, GB:SPI is a Neutral.
Spire Healthcare’s overall stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency. However, high leverage and low net profitability are concerns. Technical indicators suggest bearish momentum, and valuation metrics indicate potential overvaluation.
To see Spark’s full report on GB:SPI stock, click here.
More about Spire Healthcare
Spire Healthcare Group is a leading independent healthcare provider in the UK, operating 38 hospitals and more than 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It runs a network of private GPs and occupational health services for over 800 corporate clients, and works with more than 8,700 consultants to deliver care to over 1 million patients a year. The group is the UK’s largest private provider of knee and hip operations by volume, offers a range of private and NHS services including mental health, musculoskeletal and dermatology via its Vita Health Group brand, and reports that 98% of its inspected facilities are rated “Good” or “Outstanding” or equivalent. Spire is listed on the London Stock Exchange and is a member of the FTSE 250 index.
Average Trading Volume: 1,650,254
Technical Sentiment Signal: Sell
Current Market Cap: £717M
Learn more about SPI stock on TipRanks’ Stock Analysis page.